• Find people
• Intranet

News

24/02/2023 - Institutional news

New research group in Comparative and Functional Genomics at the Hospital del Mar Medical Research Institute.

It is led by Dr. Mario Cáceres, ICREA researcher who joins IMIM-Hospital del Mar in its talent attraction program. The group focuses on the application of the latest techniques in the field of genomics to analyze the relationship between changes in the genome and various fields of health.

Dr. Mario Cáceres joins IMIM-Hospital del Mar heading a new research group, the Comparative and Functional Genomics Research Group. The arrival of Dr. Cáceres Aguilar, ICREA researcher, has come about thanks to the talent attraction program launched at the institution to boost the research carried out with top-level researchers.

The new group will use an approach that combines experimental analysis and bioinformatics to study the functional and evolutionary impact of changes in our genome, focusing especially on inversions and other complex changes, about which still very little is known. To this end, they will apply the most advanced tools in this field, developing new methods for the study of these DNA variants.

Dr. Mario Cáceres

Doctorate from the Autonomous University of Barcelona for his work on chromosomal rearrangements in Drosophila. He continued his postdoctoral training at the Salk Institute for Biological Studies and Emory University, where his research evolved to the use of new genomic techniques to compare gene expression levels in humans and other primates, as a way to study the specific characteristics of the human species. In 2006 he obtained a Ramon y Cajal grant at the Center for Genomic Regulation in Barcelona, and focused on the identification of genomic changes with possible functional consequences in the human lineage, mainly related to inversions and other types of different structural variants. In 2010 he joined ICREA and joined the Institute of Biotechnology and Biomedicine at UAB, where he created the Comparative and Functional Genomics Group.

More news